Emerging Mechanisms of NK Cell Dysfunction in Endometriosis: The Role of Autophagy, Metabolism, Cytokines, Exosomes, and Trogocytosis

Endometriosis (EMS) is a persistent, inflammatory condition that relies on estrogen and is distinguished by the proliferation of endometrial tissue outside the confines of the uterus. The impact on the well-being of individuals affected can be significant, as it is linked to pelvic pain and reduced fertility in women of reproductive age. Over 30 years have passed since initially discovering a malfunction in the activity of natural killer (NK) cells in individuals with EMS. Several aspects that contribute to NK cell dysfunction have been explored by researchers over the years, such as the upregulation of inhibitory receptors, downregulation of activating receptors, and the exhaustion process. Nonetheless, there are still many aspects that have yet to be identified. The objective of this review is to explore whether there is a connection between mechanisms that have not yet been explored and the malfunctioning of EMS-derived NK cells. Autophagy, metabolism, trogocytosis, tunneling nanotubes (TNT), and exosomes are among the factors that play a role in these processes. The primary objective of this publication is to provide valuable insights for future research on NK cells, with the aim of enhancing our understanding of the disease's causes and identifying more effective targets for immunotherapy. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

- 1C. Chapron, L. Marcellin, B. Borghese, and P. Santulli, “Rethinking Mechanisms, Diagnosis and Management of Endometriosis,” Nature Reviews Endocrinology 15, no. 11 (2019): 666–682. - 2Y. Wang, K. Nicholes, and I.-M. Shih, “The Origin and Pathogenesis of Endometriosis,” Annual Review of Pathology: Mechanisms of Disease 15 (2020): 71–95. - 3C. von Rokitansky, “Ueber Uterusdrusen-Neubildung in Uterus and Ovariul Sarcomen,” Zeitschrift der K. K. Gesellschaft der Aerzte zu Wien 16 (1860): 577. - 4J. A. Sampson, “Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue Into the Venous Circulation,” American Journal of Pathology 3, no. 2 (1927): 93–110.43. - 5L. K. Symons, J. E. Miller, V. R. Kay, et al., “The Immunopathophysiology of Endometriosis,” Trends in Molecular Medicine 24, no. 9 (2018): 748–762. - 6D. J. Oosterlynck, F. J. Cornillie, M. Waer, M. Vandeputte, and P. R. Koninckx, “Women With Endometriosis Show a Defect in Natural Killer Activity Resulting in a Decreased Cytotoxicity to Autologous Endometrium,” Fertility and Sterility 56, no. 1 (1991): 45–51. - 7D. J. Oosterlynck, C. Meuleman, M. Waer, M. Vandeputte, and P. R. Koninckx, “The Natural Killer Activity of Peritoneal Fluid Lymphocytes Is Decreased in Women With Endometriosis,” Fertility and Sterility 58, no. 2 (1992): 290–295. - 8L. L. Lanier, “Up on the Tightrope: Natural Killer Cell Activation and Inhibition,” Nature Immunology 9, no. 5 (2008): 495–502. - 9F. Ghaedrahmati, N. Esmaeil, V. Akbari, and F. Ashrafi, “More Balance Toward Activating Receptors and Cytotoxic Activity of NK Cells Ex Vivo Differentiated From Human Umbilical Cord Blood-Derived CD34(+) Stem Cells in Comparison With Peripheral Blood NK Cells,” Heliyon 10, no. 15 (2024): e35509. - 10N. Maeda, C. Izumiya, Y. Yamamoto, H. Oguri, T. Kusume, and T. Fukaya, “Increased Killer Inhibitory Receptor KIR2DL1 Expression Among Natural Killer Cells in Women With Pelvic Endometriosis,” Fertility and Sterility 77, no. 2 (2002): 297–302. - 11H. Xu, “Expressions of Natural Cytotoxicity Receptor, NKG2D and NKG2D Ligands in Endometriosis,” Journal of Reproductive Immunology 136 (2019): 102615. - 12R. Galandrini, M. G. Porpora, A. Stoppacciaro, et al., “Increased Frequency of Human Leukocyte Antigen–E Inhibitory Receptor CD94/NKG2A–Expressing Peritoneal Natural Killer Cells in Patients With Endometriosis,” Fertility and Sterility 89, no. 5 (2008): 1490–1496. - 13A. Funamizu, A. Fukui, M. Kamoi, et al., “Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women With Endometriosis,” American Journal of Reproductive Immunology (New York, NY: 1989) 71, no. 4 (2014): 359–367. - 14R. Hosseinzadeh, A. Moini, R. Hosseini, et al., “A Higher Number of Exhausted Local PD1+, but Not TIM3+, NK Cells in Advanced Endometriosis,” Heliyon 10, no. 1 (2024): e23294. - 15M. Sadłocha, J. Toczek, K. Major, J. Staniczek, and R. Stojko, “Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies—Comprehensive Literature Review,” Pharmaceuticals 17, no. 7 (2024): 827. - 16L. García-Izquierdo, P. Marín-Sánchez, P. García-Peñarrubia, and M. Martínez-Esparza, “New Potential Pharmacological Options for Endometriosis Associated Pain,” International Journal of Molecular Sciences 25, no. 13 (2024): 7068. - 17R. Mamillapalli, A. Golden, H. S. Taylor, and N. Gawde, “Targeting PD1/PD-L1/PD-L2 Signaling in Endometriosis,” Fertility and Sterility 120, no. 4 (2023): e307. - 18M. Walankiewicz, E. Grywalska, G. Polak, et al., “The Increase of Circulating PD-1-and PD-L1-Expressing Lymphocytes in Endometriosis: Correlation With Clinical and Laboratory Parameters,” Mediators of Inflammation 2018, no. 1 (2018): 7041342. - 19S. Mohammadzadeh, A. Andalib, H. Khanahmad, and N. Esmaeil, “Human Recombinant Soluble PD1 Can Interference in T Cells and Treg Cells Function in Response to MDA-MB-231 Cancer Cell Line,” American Journal of Clinical and Experimental Immunology 12, no. 2 (2023): 11–23. - 20Q. Li, G. Peng, H. Liu, L. Wang, R. Lu, and L. Li, “Molecular Mechanisms of Secretory Autophagy and Its Potential Role in Diseases,” Life Sciences 347 (2024): 122653. - 21J. Mei, X.-Y. Zhu, L.-P. Jin, Z.-L. Duan, D.-J. Li, and M.-Q. Li, “Estrogen Promotes the Survival of Human Secretory Phase Endometrial Stromal Cells via CXCL12/CXCR4 Up-Regulation-Mediated Autophagy Inhibition,” Human Reproduction 30, no. 7 (2015): 1677–1689. - 22S. T. Lei, Z. Z. Lai, S. H. Hou, Y. K. Liu, M. Q. Li, and D. Zhao, “Abnormal HCK/Glutamine/Autophagy Axis Promotes Endometriosis Development by Impairing Macrophage Phagocytosis,” Cell Proliferation 57 (2024): e13702. - 23H. L. Yang, J. Mei, K. K. Chang, W. J. Zhou, L. Q. Huang, and M. Q. Li, “Autophagy in Endometriosis,” American Journal of Translational Research 9, no. 11 (2017): 4707–4725. - 24J. Mei, W.-J. Zhou, X.-Y. Zhu, et al., “Suppression of Autophagy and HCK Signaling Promotes PTGS2high FCGR3−NK Cell Differentiation Triggered by Ectopic Endometrial Stromal Cells,” Autophagy 14, no. 8 (2018): 1376–1397. - 25A. Ruiz, S. Rockfield, N. Taran, et al., “Effect of Hydroxychloroquine and Characterization of Autophagy in a Mouse Model Of Endometriosis,” Cell Death & Disease 7, no. 1 (2016): e2059. - 26B. Zhang, W.-J. Zhou, C.-J. Gu, et al., “The Ginsenoside PPD Exerts Anti-Endometriosis Effects by Suppressing Estrogen Receptor-Mediated Inhibition of Endometrial Stromal Cell Autophagy and NK Cell Cytotoxicity,” Cell Death & Disease 9, no. 5 (2018): 574. - 27A. Kim, K. Kang, H. Kim, et al., “A Ginseng Metabolite, Compound K, Induces Autophagy and Apoptosis via Generation of Reactive Oxygen Species and Activation of JNK in Human Colon Cancer Cells,” Cell Death & Disease 4, no. 8 (2013): e750. - 28H. Ren, R. Dai, Y. Chen, Z. Xi, and H. Xu, “How Ginseng Regulates Autophagy: Insights From Multistep Process,” Biomedicine & Pharmacotherapy 158 (2023): 114139. - 29S. Chen, J. He, X. Qin, et al., “Ginsenoside Metabolite 20 (S)‑Protopanaxadiol Promotes Neural Stem Cell Transition From a State of Proliferation to Differentiation by Inducing Autophagy and Cell Cycle Arrest,” Molecular Medicine Reports 22, no. 1 (2020): 353–361. - 30J.-J. Yu, H.-T. Sun, Z.-F. Zhang, et al., “IL15 Promotes Growth and Invasion of Endometrial Stromal Cells and Inhibits Killing Activity of NK Cells in Endometriosis,” Reproduction (Cambridge, England) 152, no. 2 (2016): 151–160. - 31E. Viry, J. Baginska, G. Berchem, et al., “Autophagic Degradation of GZMB/Granzyme B: A New Mechanism of Hypoxic Tumor Cell Escape From Natural Killer Cell-Mediated Lysis,” Autophagy 10, no. 1 (2014): 173–175. - 32R. Wang, X. Ma, X. Zhang, et al., “Autophagy-Mediated NKG2D Internalization Impairs NK Cell Function and Exacerbates Radiation Pneumonitis,” Frontiers in Immunology 14 (2023): 1250920. - 33F. M. Wensveen, V. Jelenčić, and B. Polić, “NKG2D: A Master Regulator of Immune Cell Responsiveness,” Frontiers in Immunology 9 (2018): 441. - 34M. Rigoulet, C. L. Bouchez, P. Paumard, et al., “Cell Energy Metabolism: An Update,” Biochimica Et Biophysica Acta Bioenergetics 1861, no. 11 (2020): 148276. - 35M. Hortová-Kohoutková, P. Lázničková, and J. Frič, “How Immune-Cell Fate and Function Are Determined by Metabolic Pathway Choice: The Bioenergetics Underlying the Immune Response,” BioEssays 43, no. 2 (2021): 2000067. - 36M. D. Kornberg, “The Immunologic Warburg Effect: Evidence and Therapeutic Opportunities in Autoimmunity,” Wiley Interdisciplinary Reviews Systems Biology and Medicine 12, no. 5 (2020): e1486. - 37Y. Gou, H. Wang, T. Wang, et al., “Ectopic Endometriotic Stromal Cells-Derived Lactate Induces M2 Macrophage Polarization via Mettl3/Trib1/ERK/STAT3 Signalling Pathway in Endometriosis,” Immunology 168, no. 3 (2023): 389–402. - 38P. Apostolova and E. L. Pearce, “Lactic Acid and Lactate: Revisiting the Physiological Roles in the Tumor Microenvironment,” Trends in Immunology 43, no. 12 (2022): 969–977. - 39K. Y. Hsiao, S. C. Lin, M. H. Wu, and S. J. Tsai, “Pathological Functions of Hypoxia in Endometriosis,” Frontiers in Bioscience (Elite Edition) 7, no. 2 (2015): 309–321. - 40B. McKinnon, D. Bertschi, C. Wotzkow, N. A. Bersinger, J. Evers, and M. D. Mueller, “Glucose Transporter Expression in Eutopic Endometrial Tissue and Ectopic Endometriotic Lesions,” Journal of Molecular Endocrinology 52, no. 2 (2014): 169–179. - 41S. J. Kierans and C. T. Taylor, “Regulation of Glycolysis by the Hypoxia-Inducible Factor (HIF): Implications for Cellular Physiology,” Journal of Physiology 599, no. 1 (2021): 23–37. - 42H. Peng, L. Weng, S. Lei, et al., “Hypoxia-Hindered Methylation of PTGIS in Endometrial Stromal Cells Accelerates Endometriosis Progression by Inducing CD16(-) NK-Cell Differentiation,” Experimental & Molecular Medicine 54, no. 7 (2022): 890–905. - 43C. Yunna, H. Mengru, W. Lei, and C. Weidong, “Macrophage M1/M2 Polarization,” European Journal of Pharmacology 877 (2020): 173090. - 44S. M. Poznanski, K. Singh, T. M. Ritchie, et al., “Metabolic Flexibility Determines Human NK Cell Functional Fate in the Tumor Microenvironment,” Cell Metabolism 33, no. 6 (2021): 1205.e5–1220.e5. - 45X.-T. Liu, H.-T. Sun, Z.-F. Zhang, et al., “Indoleamine 2, 3-Dioxygenase Suppresses the Cytotoxicity of NK Cells in Response to Ectopic Endometrial Stromal Cells in Endometriosis,” Reproduction (Cambridge, England) 156, no. 5 (2018): 397–404. - 46M. T. Pallotta, S. Rossini, C. Suvieri, et al., “Indoleamine 2,3-Dioxygenase 1 (IDO1): An Up-to-Date Overview of an Eclectic Immunoregulatory Enzyme,” FEBS Journal 289, no. 20 (2022): 6099–6118. - 47H. Song, H. Park, Y.-S. Kim, et al., “L-Kynurenine-Induced Apoptosis in Human NK Cells Is Mediated by Reactive Oxygen Species,” International Immunopharmacology 11, no. 8 (2011): 932–938. - 48A. Adilbayeva and J. Kunz, “Pathogenesis of Endometriosis and Endometriosis-Associated Cancers,” International Journal of Molecular Sciences 25, no. 14 (2024): 7624. - 49A. Y. Mah and M. A. Cooper, “Metabolic Regulation of Natural Killer Cell IFN-γ Production,” Critical Reviews™ in Immunology 36, no. 2 (2016): 131–147. - 50K. L. O'Brien and D. K. Finlay, “Immunometabolism and Natural Killer Cell Responses,” Nature Reviews Immunology 19, no. 5 (2019): 282–290. - 51M. L. Dustin, “The Immunological Synapse,” Cancer Immunology Research 2, no. 11 (2014): 1023–1033. - 52H.-L. Yang, W.-J. Zhou, K.-K. Chang, et al., “The Crosstalk Between Endometrial Stromal Cells and Macrophages Impairs Cytotoxicity of NK Cells in Endometriosis by Secreting IL-10 and TGF-β,” Reproduction (Cambridge, England) 154, no. 6 (2017): 815–825. - 53H. Kanzaki, H.-S. Wang, M. Kariya, and T. Mori, “Suppression of Natural Killer Cell Activity by Sera From Patients With Endometriosis,” American Journal of Obstetrics and Gynecology 167, no. 1 (1992): 257–261. - 54D. J. Oosterlynck, C. Meuleman, M. Waer, P. R. Koninckx, and M. Vandeputte, “Immunosuppressive Activity of Peritoneal Fluid in Women With Endometriosis,” Obstetrics & Gynecology 82, no. 2 (1993): 206–212. - 55T. Harada, T. Iwabe, and N. Terakawa, “Role of Cytokines in Endometriosis,” Fertility and Sterility 76, no. 1 (2001): 1–10. - 56I. Jeung, K. Cheon, and M.-R. Kim, “Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis,” BioMed Research International 2016, no. 1 (2016): 2916070. - 57Y. J. Kang, I. C. Jeung, A. Park, et al., “An increased Level of IL-6 Suppresses NK Cell Activity in Peritoneal Fluid of Patients With Endometriosis via Regulation of SHP-2 Expression,” Human Reproduction (Oxford, England) 29, no. 10 (2014): 2176–2189. - 58T. Tanaka, M. Narazaki, and T. Kishimoto, “IL-6 in Inflammation, Immunity, and Disease,” Cold Spring Harbor Perspectives in Biology 6, no. 10 (2014): a016295. - 59E. Björk, M. T. Vinnars, I. Nagaev, et al., “Enhanced Local and Systemic Inflammatory Cytokine mRNA Expression in Women With Endometriosis Evokes Compensatory Adaptive Regulatory mRNA Response That Mediates Immune Suppression and Impairs Cytotoxicity,” American Journal of Reproductive Immunology 84, no. 4 (2020): e13298. - 60A. Taylor, J. Verhagen, K. Blaser, M. Akdis, and C. A. Akdis, “Mechanisms of Immune Suppression by Interleukin-10 and Transforming Growth Factor-β: The Role of T Regulatory Cells,” Immunology 117, no. 4 (2006): 433–442. - 61X. M. Wang, Z. Y. Ma, and N. Song, “Inflammatory Cytokines IL-6, IL-10, IL-13, TNF-α and Peritoneal Fluid Flora Were Associated With Infertility in Patients With Endometriosis,” European Review for Medical and Pharmacological Sciences 22, no. 9 (2018): 2513–2518. - 62S. W. Guo, Y. Du, and X. Liu, “Platelet-Derived TGF-β1 Mediates the Down-Modulation of NKG2D Expression and May Be Responsible for Impaired Natural Killer (NK) Cytotoxicity in Women With Endometriosis,” Human Reproduction (Oxford, England) 31, no. 7 (2016): 1462–1474. - 63J. L. Suen, Y. Chang, P. R. Chiu, et al., “Serum Level of IL-10 is Increased in Patients With Endometriosis, and IL-10 Promotes the Growth of Lesions in a Murine Model,” American Journal of Pathology 184, no. 2 (2014): 464–471. - 64S. Tamburro, M. Canis, E. Albuisson, P. Dechelotte, C. Darcha, and G. Mage, “Expression of Transforming Growth Factor β1 in Nerve Fibers Is Related to Dysmenorrhea and Laparoscopic Appearance of Endometriotic Implants,” Fertility and Sterility 80, no. 5 (2003): 1131–1136. - 65S. Viel, A. Marçais, F. S. Guimaraes, et al., “TGF-β Inhibits the Activation and Functions of NK Cells by Repressing the mTOR Pathway,” Science Signaling 9, no. 415 (2016): ra19. - 66M. D. Buck, D. O'Sullivan, and E. L. Pearce, “T Cell Metabolism Drives Immunity,” Journal of Experimental Medicine 212, no. 9 (2015): 1345–1360. - 67A. Marçais, J. Cherfils-Vicini, C. Viant, et al., “The Metabolic Checkpoint Kinase mTOR Is Essential for IL-15 Signaling During the Development and Activation of NK Cells,” Nature Immunology 15, no. 8 (2014): 749–757. - 68A. Nakamura, Y. Tanaka, T. Amano, et al., “mTOR Inhibitors as Potential Therapeutics for Endometriosis: A Narrative Review,” Molecular Human Reproduction 30, no. 12 (2024): gaae041. - 69G. van Niel, G. D'Angelo, and G. Raposo, “Shedding Light on the Cell Biology of Extracellular Vesicles,” Nature Reviews Molecular Cell Biology 19, no. 4 (2018): 213–228. - 70E. Björk, P. Israelsson, I. Nagaev, et al., “Endometriotic Tissue–Derived Exosomes Downregulate NKG2D-Mediated Cytotoxicity and Promote Apoptosis: Mechanisms for Survival of Ectopic Endometrial Tissue in Endometriosis,” Journal of Immunology 213, no. 5 (2024): 567–576. - 71H. M. Nazri, M. Imran, R. Fischer, et al., “Characterization of Exosomes in Peritoneal Fluid of Endometriosis Patients,” Fertility and Sterility 113, no. 2 (2020): 364.e2–373.e2. - 72M. Siernicka, M. Winiarska, M. Bajor, et al., “Adenanthin, a New Inhibitor of Thiol-Dependent Antioxidant Enzymes, Impairs the Effector Functions of Human Natural Killer Cells,” Immunology 146, no. 1 (2015): 173–183. - 73J.-J. Qiu, X.-J. Lin, T.-T. Zheng, X.-Y. Tang, Y. Zhang, and K.-Q. Hua, “The Exosomal Long Noncoding RNA aHIF Is Upregulated in Serum From Patients With Endometriosis and Promotes Angiogenesis in Endometriosis,” Reproductive Sciences 26, no. 12 (2019): 1590–1602. - 74J. Wu, X. Fang, H. Huang, W. Huang, L. Wang, and X. Xia, “Construction and Topological Analysis of an Endometriosis-Related Exosomal circRNA-miRNA-mRNA Regulatory Network,” Aging (Albany NY) 13, no. 9 (2021): 12607. - 75W. Zhou, Y. Lian, J. Jiang, et al., “Differential Expression of microRNA in Exosomes Derived From Endometrial Stromal Cells of Women With Endometriosis-Associated Infertility,” Reproductive Biomedicine Online 41, no. 2 (2020): 170–181. - 76S. Scheck, E. S. Paterson, and C. E. Henry, “A Promising Future for Endometriosis Diagnosis and Therapy: Extracellular Vesicles-a Systematic Review,” Reproductive Biology and Endocrinology 20, no. 1 (2022): 174. - 77Y. Huang, L. Zhu, H. Li, et al., “Endometriosis Derived Exosomal miR-301a-3p Mediates Macrophage Polarization via Regulating PTEN-PI3K Axis,” Biomedicine & Pharmacotherapy 147 (2022): 112680. - 78A. S. Pathania, P. Prathipati, O. A. Olwenyi, et al., “miR-15a and miR-15b Modulate Natural Killer and CD8+ T-Cell Activation and Anti-Tumor Immune Response by Targeting PD-L1 in Neuroblastoma,” Molecular Therapy-Oncolytics 25 (2022): 308–329. - 79J. Zhang, Y. Yang, Y. Wei, L. Li, X. Wang, and Z. Ye, “Hsa-miR-301a-3p Inhibited the Killing Effect of Natural Killer Cells on Non-Small Cell Lung Cancer Cells by Regulating RUNX3,” Cancer Biomarkers: Section A of Disease Markers 37, no. 4 (2023): 249–259. - 80J. Caumartin, B. Favier, M. Daouya, et al., “Trogocytosis-Based Generation of Suppressive NK Cells,” EMBO Journal 26, no. 5 (2007): 1423–1433. - 81M. R. Rached, V. Coelho, M. L. C. Marin, et al., “HLA-G Is Upregulated in Advanced Endometriosis,” European Journal of Obstetrics & Gynecology and Reproductive Biology 235 (2019): 36–41. - 82F. Rezayat, N. Esmaeil, P. Nikpour, A. Feizi, and A. Rezaei, “Different Behavior of NK Cells Isolated From Healthy Women and Women With Recurrent Spontaneous Abortion After Treatment With Human Amniotic Epithelial Cells,” Journal of Leukocyte Biology 117, no. 4 (2025): qiaf020. - 83R. Apps, L. Gardner, and A. Moffett, “A Critical Look at HLA-G,” Trends in Immunology 29, no. 7 (2008): 313–321. - 84A. Lin and W. H. Yan, “Intercellular Transfer of HLA-G: Its Potential in Cancer Immunology,” Clinical & Translational Immunology 8, no. 9 (2019): e1077. - 85M. S. Hasim, M. Marotel, J. J. Hodgins, et al., “When Killers Become Thieves: Trogocytosed PD-1 Inhibits NK Cells in Cancer,” Science Advances 8, no. 15 (2022): eabj3286. - 86O. Pagliano, R. M. Morrison, J.-M. Chauvin, et al., “Tim-3 Mediates T Cell Trogocytosis to Limit Antitumor Immunity,” Journal of Clinical Investigation 132, no. 9 (2022): e152864. - 87L. Wu, C. Lv, Y. Su, et al., “Expression of Programmed Death-1 (PD-1) and Its Ligand PD-L1 Is Upregulated in Endometriosis and Promoted by 17beta-Estradiol,” Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 35, no. 3 (2019): 251–256. - 88K. Nakamura, M. Nakayama, M. Kawano, et al., “Fratricide of Natural Killer Cells Dressed With Tumor-Derived NKG2D Ligand,” Proceedings of the National Academy of Sciences 110, no. 23 (2013): 9421–9426. - 89F. Ramezani, A. R. Panahi Meymandi, B. Akbari, et al., “Outsmarting Trogocytosis to Boost CAR NK/T Cell Therapy,” Molecular Cancer 22, no. 1 (2023): 183. - 90G. G. Azeze, L. Wu, B. K. Alemu, C. C. Wang, and T. Zhang, “Changes in the Number and Activity of NK Cells and Its Clinical Association With Endometriosis: Systematic Review and Meta-Analysis,” F&S Reviews 5 (2024): 100072. 10.1016/j.xfnr.2024.100072Google Scholar - 91C. Zurzolo, “Tunneling Nanotubes: Reshaping Connectivity,” Current Opinion in Cell Biology 71 (2021): 139–147. - 92A. Chauveau, A. Aucher, P. Eissmann, E. Vivier, and D. M. Davis, “Membrane Nanotubes Facilitate Long-Distance Interactions Between Natural Killer Cells and Target Cells,” Proceedings of the National Academy of Sciences 107, no. 12 (2010): 5545–5550. - 93B. Önfelt, S. Nedvetzki, K. Yanagi, and D. M. Davis, “Cutting Edge: Membrane Nanotubes Connect Immune Cells,” Journal of Immunology 173, no. 3 (2004): 1511–1513. - 94R. Basu, B. M. Whitlock, J. Husson, et al., “Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing,” Cell 165, no. 1 (2016): 100–110. - 95C. Zhu, Y. Shi, and J. You, “Immune Cell Connection by Tunneling Nanotubes: The Impact of Intercellular Cross-Talk on the Immune Response and Its Therapeutic Applications,” Molecular Pharmaceutics 18, no. 3 (2021): 772–786. - 96L. Turos-Korgul, M. D. Kolba, P. Chroscicki, A. Zieminska, and K. Piwocka, “Tunneling Nanotubes Facilitate Intercellular Protein Transfer and Cell Networks Function,” Frontiers in Cell and Developmental Biology 10 (2022): 915117. - 97T. Saha, C. Dash, R. Jayabalan, et al., “Intercellular Nanotubes Mediate Mitochondrial Trafficking Between Cancer and Immune Cells,” Nature Nanotechnology 17, no. 1 (2022): 98–106. - 98G. Pinto, C. Brou, and C. Zurzolo, “Tunneling Nanotubes: The Fuel of Tumor Progression?,” Trends in Cancer 6, no. 10 (2020): 874–888. - 99C. Chen, Y. Zhou, C. Hu, et al., “Mitochondria and Oxidative Stress in Ovarian Endometriosis,” Free Radical Biology & Medicine 136 (2019): 22–34. - 100H. Kobayashi, S. Matsubara, C. Yoshimoto, H. Shigetomi, and S. Imanaka, “The Role of Mitochondrial Dynamics in the Pathophysiology of Endometriosis,” Journal of Obstetrics and Gynaecology Research 49, no. 12 (2023): 2783–2791. Article Metrics Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information Scite metrics Explore this article's citation statements on scite.ai Share QR Code Generating QR code QR code copied to clipboard! Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support. Export citation Unable to load citation data. Please try again in a moment. How to cite Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619 Download Citation If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site. Citation manager file format Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks